FSIP1 and breast cancer: Principal discoveries in these series of experiments are FSIP1 overexpression is significantly associated with increased malignancy, invasiveness, and docetaxel resistance of human breast cancer cells, and that knocking out FSIP1 decreased the proliferation and migration, and increased the susceptibility of breast cancer cells to chemotherapeutic agents.